Use of a Share Decision Making Tool in the Care of Acute Cystitis Without Risk of Complication in Primary Care
ARIBO
Utilisation d'un Outil de décision médicale partagée Dans la Prise en Charge Des Cystites Aigues Sans Risque de Complication en médecine générale : Comparaison de la Consommation d'Antibiotique Entre Deux Groupes randomisés en Cluster.
1 other identifier
interventional
169
1 country
1
Brief Summary
the aim of this trial is to demonstrate that when caring women with symptoms of acute cystitis without any risk of complication, general practitioner may use share decision making tool to help patients better understand the stakes of taking antibiotics.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 14, 2020
CompletedFirst Posted
Study publicly available on registry
February 17, 2020
CompletedStudy Start
First participant enrolled
July 22, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
February 17, 2022
CompletedMarch 9, 2022
March 1, 2022
1.4 years
February 14, 2020
March 8, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Use of antibiotic for acute cystitis without risk of complication
Day 14 after inclusion (day 0)
Secondary Outcomes (3)
Score at the "Activity Impairment Assessment" scale
Day 0, Day 5 and Day14
Score at the satisfaction scale
Day 0, Day 5, Day14 and Day 90
Recurrence of the infection
Between Day 15 and Day 90
Study Arms (2)
Share making tool decision
EXPERIMENTALPatient recruited from general practitioner in this group will use a share making tool decision to adapt antibiotherapy
Standard recommandation
ACTIVE COMPARATORPatients recruited from general practitioner will receive the standard medical care
Interventions
The experimental group will use the share decision making tool during consultation to adapt antibiotherapy
control group will act as usual in their practice.
Eligibility Criteria
You may qualify if:
- woman
- between 18 and 65 years
- symptom of acute cystitis without risk of complication
- affiliated to the French public welfare system
- with signed consent
You may not qualify if:
- anomaly of the urinary canal
- pregnancy
- more than 3 cystitis during the last year
- cancer, immunosuppression
- hemopathy, fever
- back-pain
- severe renal failure
- refuse to give consent and previously participate to the study
- under guardianship
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Bordeaux
Bordeaux, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 14, 2020
First Posted
February 17, 2020
Study Start
July 22, 2020
Primary Completion
December 3, 2021
Study Completion
February 17, 2022
Last Updated
March 9, 2022
Record last verified: 2022-03
Data Sharing
- IPD Sharing
- Will not share